Publications by authors named "Giulia Siravegna"

46Publications

Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.

Eur Radiol 2020 Aug 19;30(8):4496-4503. Epub 2020 Mar 19.

Department of Interventional Radiology, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-020-06700-4DOI Listing
August 2020

A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.

Clin Colorectal Cancer 2019 06 7;18(2):91-101.e3. Epub 2019 Mar 7.

Candiolo Cancer Institute, FPO-IRCCS, Candiolo (TO), Italy; University of Turin, Department of Oncology, Candiolo (TO), Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2019.02.008DOI Listing
June 2019

Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies.

Cancer Treat Rev 2019 Feb 27;73:41-53. Epub 2018 Dec 27.

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy; Università degli Studi di Milano, Dipartimento di Oncologia ed Emato-Oncologia, Milano, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183021
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.12.006DOI Listing
February 2019

Blood-Based Prediction of Tumor Relapse: The cfDNA Forecast.

Cancer Discov 2018 10;8(10):1213-1215

Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/lookup/doi/10.1158/2
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-18-0952DOI Listing
October 2018

Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2018 03 1;17(1):80-83. Epub 2017 Nov 1.

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2017.10.017DOI Listing
March 2018

Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor.

Stem Cells 2017 11 29;35(11):2218-2228. Epub 2017 Sep 29.

Laboratory of Cancer Stem Cell Research, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/stem.2703
Publisher Site
http://dx.doi.org/10.1002/stem.2703DOI Listing
November 2017

Integrating liquid biopsies into the management of cancer.

Nat Rev Clin Oncol 2017 Sep 2;14(9):531-548. Epub 2017 Mar 2.

Candiolo Cancer Institute - Fondazione del Piemonte per l'Oncologia (FPO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Strada Provinciale 142, Km 3.95, 10060 Candiolo, Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.14DOI Listing
September 2017

Clonal evolution and - coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer.

ESMO Open 2016 4;1(4):e000079. Epub 2016 Aug 4.

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy; Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://esmoopen.bmj.com/lookup/doi/10.1136/esmoopen-2016-000
Publisher Site
http://dx.doi.org/10.1136/esmoopen-2016-000079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070243PMC
August 2016

Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.

Mol Oncol 2016 Mar 17;10(3):475-80. Epub 2015 Dec 17.

University of Torino, Department of Oncology, SP 142, KM 3.95, 10060 Candiolo, Torino, Italy; Candiolo Cancer Institute - FPO, IRCCS, Candiolo, Torino, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.12.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528968PMC
March 2016

Minimal residual disease in breast cancer: in blood veritas.

Clin Cancer Res 2014 May 21;20(10):2505-7. Epub 2014 Mar 21.

Authors' Affiliations: Department of Oncology, University of Turin; Candiolo Cancer Institute-FPO, IRCCS, Turin; and FIRC Institute of Molecular Oncology (IFOM), Milan, ItalyAuthors' Affiliations: Department of Oncology, University of Turin; Candiolo Cancer Institute-FPO, IRCCS, Turin; and FIRC Institute of Molecular Oncology (IFOM), Milan, ItalyAuthors' Affiliations: Department of Oncology, University of Turin; Candiolo Cancer Institute-FPO, IRCCS, Turin; and FIRC Institute of Molecular Oncology (IFOM), Milan, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0370DOI Listing
May 2014